The need to optimize adolescent immunization

Committee on Infectious Diseases

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an adolescent's immunizations. In the past decade, the adolescent immunization schedule has expanded to include 2 doses of quadrivalent meningococcal conjugate vaccine, 1 dose of tetanus, diphtheria, acellular pertussis, absorbed vaccine, 2 or 3 doses of human papillomavirus vaccine, depending on the child's age, and an annual influenza vaccine. In addition, during adolescent visits, health care providers can determine whether catch-up vaccination is needed to meet early childhood recommendations for hepatitis B; hepatitis A; measles, mumps, rubella; poliovirus; and varicella vaccines. New serogroup B meningococcal vaccines are now available for those at increased risk for meningococcal disease; in addition, these serogroup B meningococcal vaccines received a Category B recommendation for healthy adolescents, where individual counseling and risk-benefit evaluation based on health care provider judgements and patient preferences are indicated. This clinical report focuses on the epidemiology of adolescent vaccine-preventable diseases by reviewing the rationale for the annual universally recommended adolescent immunization schedule of the American Academy of Pediatrics, the American Academy of Family Physicians, the Centers for Disease Control and Prevention, and the American Congress of Obstetricians and Gynecologists. In addition, the barriers that negatively influence adherence to this current adolescent immunization schedule will be highlighted.

Original languageEnglish (US)
Article numbere20164186
JournalPediatrics
Volume139
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Immunization
Meningococcal Vaccines
Immunization Schedule
Health Personnel
Vaccination
Diphtheria-Tetanus-acellular Pertussis Vaccines
Preventive Health Services
Chickenpox Vaccine
Pediatrics
Papillomavirus Vaccines
Patient Transfer
Conjugate Vaccines
Mumps
Preventive Medicine
Poliovirus
Hepatitis A
Rubella
Patient Preference
Influenza Vaccines
Family Physicians

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Committee on Infectious Diseases (2017). The need to optimize adolescent immunization. Pediatrics, 139(3), [e20164186]. https://doi.org/10.1542/peds.2016-4186

The need to optimize adolescent immunization. / Committee on Infectious Diseases.

In: Pediatrics, Vol. 139, No. 3, e20164186, 01.03.2017.

Research output: Contribution to journalReview article

Committee on Infectious Diseases 2017, 'The need to optimize adolescent immunization', Pediatrics, vol. 139, no. 3, e20164186. https://doi.org/10.1542/peds.2016-4186
Committee on Infectious Diseases. The need to optimize adolescent immunization. Pediatrics. 2017 Mar 1;139(3). e20164186. https://doi.org/10.1542/peds.2016-4186
Committee on Infectious Diseases. / The need to optimize adolescent immunization. In: Pediatrics. 2017 ; Vol. 139, No. 3.
@article{c534aa1a2db4415b88792bd518a3f85b,
title = "The need to optimize adolescent immunization",
abstract = "The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an adolescent's immunizations. In the past decade, the adolescent immunization schedule has expanded to include 2 doses of quadrivalent meningococcal conjugate vaccine, 1 dose of tetanus, diphtheria, acellular pertussis, absorbed vaccine, 2 or 3 doses of human papillomavirus vaccine, depending on the child's age, and an annual influenza vaccine. In addition, during adolescent visits, health care providers can determine whether catch-up vaccination is needed to meet early childhood recommendations for hepatitis B; hepatitis A; measles, mumps, rubella; poliovirus; and varicella vaccines. New serogroup B meningococcal vaccines are now available for those at increased risk for meningococcal disease; in addition, these serogroup B meningococcal vaccines received a Category B recommendation for healthy adolescents, where individual counseling and risk-benefit evaluation based on health care provider judgements and patient preferences are indicated. This clinical report focuses on the epidemiology of adolescent vaccine-preventable diseases by reviewing the rationale for the annual universally recommended adolescent immunization schedule of the American Academy of Pediatrics, the American Academy of Family Physicians, the Centers for Disease Control and Prevention, and the American Congress of Obstetricians and Gynecologists. In addition, the barriers that negatively influence adherence to this current adolescent immunization schedule will be highlighted.",
author = "{Committee on Infectious Diseases} and Bernstein, {Henry H.} and Bocchini, {Joseph A.} and Byington, {Carrie L.} and Maldonado, {Yvonne A.} and Barnett, {Elizabeth D.} and Campbell, {James D.} and Davies, {Herbert Dele} and Ruth Lynfield and Julia Bratic and Munoz, {Flor M.} and Dawn Nolt and Nyquist, {Ann Christine} and Sean O'Leary and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Steinbach, {William J.} and Tan, {Tina Q.} and Zaoutis, {Theoklis E.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1542/peds.2016-4186",
language = "English (US)",
volume = "139",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - The need to optimize adolescent immunization

AU - Committee on Infectious Diseases

AU - Bernstein, Henry H.

AU - Bocchini, Joseph A.

AU - Byington, Carrie L.

AU - Maldonado, Yvonne A.

AU - Barnett, Elizabeth D.

AU - Campbell, James D.

AU - Davies, Herbert Dele

AU - Lynfield, Ruth

AU - Bratic, Julia

AU - Munoz, Flor M.

AU - Nolt, Dawn

AU - Nyquist, Ann Christine

AU - O'Leary, Sean

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Steinbach, William J.

AU - Tan, Tina Q.

AU - Zaoutis, Theoklis E.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an adolescent's immunizations. In the past decade, the adolescent immunization schedule has expanded to include 2 doses of quadrivalent meningococcal conjugate vaccine, 1 dose of tetanus, diphtheria, acellular pertussis, absorbed vaccine, 2 or 3 doses of human papillomavirus vaccine, depending on the child's age, and an annual influenza vaccine. In addition, during adolescent visits, health care providers can determine whether catch-up vaccination is needed to meet early childhood recommendations for hepatitis B; hepatitis A; measles, mumps, rubella; poliovirus; and varicella vaccines. New serogroup B meningococcal vaccines are now available for those at increased risk for meningococcal disease; in addition, these serogroup B meningococcal vaccines received a Category B recommendation for healthy adolescents, where individual counseling and risk-benefit evaluation based on health care provider judgements and patient preferences are indicated. This clinical report focuses on the epidemiology of adolescent vaccine-preventable diseases by reviewing the rationale for the annual universally recommended adolescent immunization schedule of the American Academy of Pediatrics, the American Academy of Family Physicians, the Centers for Disease Control and Prevention, and the American Congress of Obstetricians and Gynecologists. In addition, the barriers that negatively influence adherence to this current adolescent immunization schedule will be highlighted.

AB - The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an adolescent's immunizations. In the past decade, the adolescent immunization schedule has expanded to include 2 doses of quadrivalent meningococcal conjugate vaccine, 1 dose of tetanus, diphtheria, acellular pertussis, absorbed vaccine, 2 or 3 doses of human papillomavirus vaccine, depending on the child's age, and an annual influenza vaccine. In addition, during adolescent visits, health care providers can determine whether catch-up vaccination is needed to meet early childhood recommendations for hepatitis B; hepatitis A; measles, mumps, rubella; poliovirus; and varicella vaccines. New serogroup B meningococcal vaccines are now available for those at increased risk for meningococcal disease; in addition, these serogroup B meningococcal vaccines received a Category B recommendation for healthy adolescents, where individual counseling and risk-benefit evaluation based on health care provider judgements and patient preferences are indicated. This clinical report focuses on the epidemiology of adolescent vaccine-preventable diseases by reviewing the rationale for the annual universally recommended adolescent immunization schedule of the American Academy of Pediatrics, the American Academy of Family Physicians, the Centers for Disease Control and Prevention, and the American Congress of Obstetricians and Gynecologists. In addition, the barriers that negatively influence adherence to this current adolescent immunization schedule will be highlighted.

UR - http://www.scopus.com/inward/record.url?scp=85015998071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015998071&partnerID=8YFLogxK

U2 - 10.1542/peds.2016-4186

DO - 10.1542/peds.2016-4186

M3 - Review article

VL - 139

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

M1 - e20164186

ER -